Intrahepatic cholangiocarcinoma (ICC), the second most common primary liver cancer after hepatocellular carcinoma (HCC), exhibits high YBX1 expression, which correlates with poor patient prognosis. Here, YBX1 is linked to intrahepatic cholangiocarcinoma.